AstraZeneca Appoints Roche’s Sean Bohen as Chief Medical Officer
This article is for subscribers only.
AstraZeneca Plc hired Sean Bohen as chief medical officer, poaching a cancer drug expert from Roche Holding AG’s Genentech division to lead its efforts to find new treatments.
Bohen will join the company on Sept. 15 and oversee the development of drugs through late-stage testing to regulatory approval, London-based AstraZeneca said on Monday in a statement. At Genentech, he oversaw early drug development across all therapy areas, including oncology, respiratory and autoimmune diseases.